Global Animal Antibiotics and Antimicrobials Market Size Study, by Product, Mode of Delivery, Animal and Regional Forecasts 2022-2032

Description

The global Animal Antibiotics and Antimicrobials market is currently valued at approximately USD 5.04 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 3.60% during the forecast period from 2024 to 2032. The market has witnessed a remarkable evolution, driven by the increasing focus on safeguarding animal health, which directly impacts food security and human health. With the rising prevalence of zoonotic diseases and the growing demand for high-quality protein sources, antibiotics and antimicrobials have become essential tools in both therapeutic and preventive veterinary care.

The proliferation of food-producing animals has significantly amplified the demand for antibiotics and antimicrobials, with tetracycline and penicillin accounting for substantial market shares due to their broad-spectrum efficacy. Meanwhile, advanced delivery methods such as oral solutions and premixes are revolutionizing treatment accessibility, particularly in large-scale farming operations. Furthermore, the surge in pet ownership has catalyzed the demand for companion animal therapeutics, thereby diversifying the market's application spectrum.

Despite its promising growth, the market grapples with challenges such as stringent regulations on antimicrobial usage to curb resistance and a shift toward alternatives in line with global health initiatives. However, innovations in antimicrobial formulations and strategic alliances to expand market reach are poised to mitigate these challenges. The emergence of sustainable practices and precision medicine in animal health offers a promising horizon for market stakeholders.

Regionally, North America dominates the animal antibiotics and antimicrobials market, attributed to its advanced veterinary infrastructure and strong regulatory oversight ensuring the judicious use of antimicrobials. Europe follows closely, benefiting from stringent policies that promote sustainable animal farming practices. In contrast, the Asia-Pacific region is expected to witness the fastest growth, driven by increasing livestock populations, burgeoning meat consumption, and government initiatives aimed at improving veterinary healthcare infrastructure in emerging economies such as India and China.

Major market players included in this report are:

Zoetis Inc.
Elanco Animal Health Incorporated
Merck Animal Health
Boehringer Ingelheim
Ceva Sante Animale
Virbac
Phibro Animal Health Corporation
Vetoquinol
Bayer Animal Health
Dechra Pharmaceuticals PLC
Zydus Animal Health
Huvepharma
Norbrook Laboratories Limited
Neogen Corporation
HIPRA

The detailed segments and sub-segment of the market are explained below:

By Product

Tetracycline
Penicillin
Sulfonamide
Macrolide
Cephalosporin
Lincosamide

By Mode of Delivery

Premixes
Oral Solution
Injection

By Animal

Food Producing
Companion

By Region:

North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
Rest of Europe
Asia Pacific
China
India
Japan
Australia
South Korea
Rest of Asia Pacific
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Years considered for the study are as follows:

Historical year - 2022
Base year - 2023
Forecast period - 2024 to 2032

Key Takeaways:

Market estimates and forecasts spanning a decade from 2022 to 2032.
Regional insights, with country-level analyses for major markets.
Competitive landscape profiling key market players and their strategic initiatives.
Actionable recommendations tailored for market participants.

Chapter 1. Global Animal Antibiotics and Antimicrobials Market Executive Summary

1.1. Global Animal Antibiotics and Antimicrobials Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
- 1.3.1. By Product
  - 1.3.1.1. Tetracycline
  - 1.3.1.2. Penicillin
  - 1.3.1.3. Sulfonamide
  - 1.3.1.4. Macrolide
  - 1.3.1.5. Cephalosporin
  - 1.3.1.6. Lincosamide
- 1.3.2. By Mode of Delivery
  - 1.3.2.1. Premixes
  - 1.3.2.2. Oral Solution
  - 1.3.2.3. Injection
- 1.3.3. By Animal
  - 1.3.3.1. Food Producing
  - 1.3.3.2. Companion
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Animal Antibiotics and Antimicrobials Market Definition and Research Assumptions

2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
- 2.3.1. Inclusion & Exclusion
- 2.3.2. Limitations
- 2.3.3. Supply Side Analysis
  - 2.3.3.1. Availability
  - 2.3.3.2. Infrastructure
  - 2.3.3.3. Regulatory Environment
  - 2.3.3.4. Market Competition
  - 2.3.3.5. Economic Viability (Consumer's Perspective)
- 2.3.4. Demand Side Analysis
  - 2.3.4.1. Regulatory Frameworks
  - 2.3.4.2. Technological Advancements
  - 2.3.4.3. Environmental Considerations
  - 2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates

Chapter 3. Global Animal Antibiotics and Antimicrobials Market Dynamics

3.1. Market Drivers
- 3.1.1. Increasing Focus on Animal Health and Food Security
- 3.1.2. Rising Prevalence of Zoonotic Diseases
- 3.1.3. Growing Demand for High-Quality Protein Sources
3.2. Market Challenges
- 3.2.1. Stringent Regulations on Antimicrobial Usage
- 3.2.2. Emergence of Antimicrobial Resistance
3.3. Market Opportunities
- 3.3.1. Innovations in Antimicrobial Formulations
- 3.3.2. Strategic Alliances to Expand Market Reach
- 3.3.3. Adoption of Sustainable and Precision Medicine Practices

Chapter 4. Global Animal Antibiotics and Antimicrobials Market Industry Analysis

4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.1.6. Futuristic Approach to Porter's 5 Force Model
- 4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
- 4.2.1. Political
- 4.2.2. Economical
- 4.2.3. Social
- 4.2.4. Technological
- 4.2.5. Environmental
- 4.2.6. Legal
4.3. Top Investment Opportunities
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Animal Antibiotics and Antimicrobials Market Size & Forecasts by Product 2022-2032

5.1. Segment Dashboard
5.2. Global Animal Antibiotics and Antimicrobials Market: Product Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
- 5.2.1. Tetracycline
- 5.2.2. Penicillin
- 5.2.3. Sulfonamide
- 5.2.4. Macrolide
- 5.2.5. Cephalosporin
- 5.2.6. Lincosamide

Chapter 6. Global Animal Antibiotics and Antimicrobials Market Size & Forecasts by Mode of Delivery 2022-2032

6.1. Segment Dashboard
6.2. Global Animal Antibiotics and Antimicrobials Market: Mode of Delivery Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
- 6.2.1. Premixes
- 6.2.2. Oral Solution
- 6.2.3. Injection

Chapter 7. Global Animal Antibiotics and Antimicrobials Market Size & Forecasts by Animal 2022-2032

7.1. Segment Dashboard
7.2. Global Animal Antibiotics and Antimicrobials Market: Animal Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
- 7.2.1. Food Producing
- 7.2.2. Companion

Chapter 8. Competitive Intelligence

8.1. Key Company SWOT Analysis
- 8.1.1. Zoetis Inc.
- 8.1.2. Elanco Animal Health Incorporated
- 8.1.3. Merck Animal Health
8.2. Top Market Strategies
8.3. Company Profiles
- 8.3.1. Zoetis Inc.
  - 8.3.1.1. Key Information
  - 8.3.1.2. Overview
  - 8.3.1.3. Financial (Subject to Data Availability)
  - 8.3.1.4. Product Summary
  - 8.3.1.5. Market Strategies
- 8.3.2. Elanco Animal Health Incorporated
- 8.3.3. Merck Animal Health
- 8.3.4. Boehringer Ingelheim
- 8.3.5. Ceva Sante Animale
- 8.3.6. Virbac
- 8.3.7. Phibro Animal Health Corporation
- 8.3.8. Vetoquinol
- 8.3.9. Bayer Animal Health
- 8.3.10. Dechra Pharmaceuticals PLC
- 8.3.11. Zydus Animal Health
- 8.3.12. Huvepharma
- 8.3.13. Norbrook Laboratories Limited
- 8.3.14. Neogen Corporation
- 8.3.15. HIPRA

Chapter 9. Research Process

9.1. Research Process
- 9.1.1. Data Mining
- 9.1.2. Analysis
- 9.1.3. Market Estimation
- 9.1.4. Validation
- 9.1.5. Publishing
9.2. Research Attributes